Molecular modelling of quinoline derivatives as telomerase inhibitors through 3D-QSAR, molecular dynamics simulation, and molecular docking techniques K Vishwakarma, H Bhatt Journal of Molecular Modeling 27, 1-16, 2021 | 12 | 2021 |
Telomerase: A prominent oncological target for development of chemotherapeutic agents K Vishwakarma, R Dey, H Bhatt European Journal of Medicinal Chemistry 249, 115121, 2023 | 10 | 2023 |
Synthesis and biological evaluation of β-carboline derivatives as an anxiolytic agents RSPPKS Keerti Vishwakarma, Shilpi Jain, Harish Rajak Der Pharma Chemica 6 ((1)), 472-476, 2014 | 3 | 2014 |
The retroactive and future potentials of Aurora kinases in the treatment of cancer H Bhatt, K Vishwakarma, S Shaw Protein Kinase Inhibitors, 323-360, 2022 | | 2022 |
FORCED DEGRADATION STUDY FOR ESTIMATION OF RELATED SUBSTANCES AND DEGRADANTS IN ALLOPURINOL TABLET AND ITS METHOD VALIDATION USING RP-HPLC PKS Manjri Kharia, Keerti Vishwakarma Indo American Journal of Pharmaceutical Research 8 (06), 1367-1373, 2018 | | 2018 |
SCREENING OF ANTICONVULSANT ACTIVITY OF SOME NEWLY SYNTHESIZED PHTHALIMIDE DERIVATIVES S Tiwari, K Vishwakarma, N Jain, PK Singour Pharma Science Monitor 5 (3), 2014 | | 2014 |